PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Hospital laboratories - Market size and forecast 2018-2023 • Clinical research laboratories and medical institutes - Market size and forecast 2018-2023 • Reference laboratories - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS • Technological advances in molecular diagnostics • Advances in genomics and proteomics • Improving healthcare infrastructure in emerging economies PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Enzo Biochem Inc. • Eurofins Scientific • Laboratory Corporation of America Holdings • Quest Diagnostics Incorporated • Sonic Healthcare PART 13: APPENDIX • Research methodology • List of abbreviations   Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ billions) Exhibit 08: Global market Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Hospital laboratories - Market size and forecast 2018-2023 ($ billions) Exhibit 20: Hospital laboratories - Year-over-year growth 2019-2023 (%) Exhibit 21: Clinical research laboratories and medical institutes - Market size and forecast 2018-2023 ($ billions) Exhibit 22: Clinical research laboratories and medical institutes - Year-over-year growth 2019-2023 (%) Exhibit 23: Reference laboratories - Market size and forecast 2018-2023 ($ billions) Exhibit 24: Reference laboratories - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ billions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ billions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ billions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ billions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Enzo Biochem Inc. - Vendor overview Exhibit 46: Enzo Biochem Inc. - Business segments Exhibit 47: Enzo Biochem Inc. - Organizational developments Exhibit 48: Enzo Biochem Inc. - Geographic focus Exhibit 49: Enzo Biochem Inc. - Segment focus Exhibit 50: Enzo Biochem Inc. - Segment focus Exhibit 51: Enzo Biochem Inc. - Key offerings Exhibit 52: Eurofins Scientific - Vendor overview Exhibit 53: Eurofins Scientific - Product segments Exhibit 54: Eurofins Scientific - Organizational developments Exhibit 55: Eurofins Scientific - Segment focus Exhibit 56: Eurofins Scientific - Key offerings Exhibit 57: Laboratory Corporation of America Holdings - Vendor overview Exhibit 58: Laboratory Corporation of America Holdings - Business segments Exhibit 59: Laboratory Corporation of America Holdings - Organizational developments Exhibit 60: Laboratory Corporation of America Holdings - Geographic focus Exhibit 61: Laboratory Corporation of America Holdings - Segment focus Exhibit 62: Laboratory Corporation of America Holdings - Key offerings Exhibit 63: Quest Diagnostics Incorporated - Vendor overview Exhibit 64: Quest Diagnostics Incorporated - Business segments Exhibit 65: Quest Diagnostics Incorporated - Organizational developments Exhibit 66: Quest Diagnostics Incorporated - Segment focus Exhibit 67: Quest Diagnostics Incorporated - Key offerings Exhibit 68: Sonic Healthcare - Vendor overview Exhibit 69: Sonic Healthcare - Business segments Exhibit 70: Sonic Healthcare - Organizational developments Exhibit 71: Sonic Healthcare - Geographic focus Exhibit 72: Sonic Healthcare - Segment focus Exhibit 73: Sonic Healthcare - Key offerings Exhibit 74: Validation techniques employed for market sizing

Enzo Biochem Inc. Eurofins Scientific Laboratory Corporation of America Holdings Quest Diagnostics Incorporated Sonic Healthcare